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Abstract: In this case, a 31-year-old male suffered phantom neuropathic pain for more than 
3 years after an above-the-knee amputation. His shooting phantom pain disappeared after the first 
session of breathing-controlled electrical stimulation, and reappeared or was triggered 28 days 
after an experimental error during which he received sustained electrical stimulation. In other 
words, painful shooting stimuli may not have been “cured” but forgotten and retriggered by a 
fearful event due to the experimental error. Therefore, this accidental finding provides a unique 
opportunity to understand sensory and affective components of neuropathic pain, and a novel 
intervention could modify the affective component of it.
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Introduction
Neuropathic pain, including phantom pain, is a chronic condition caused by a primary 
lesion or dysfunction of the nervous system.1 Neuropathic pain is very common.2 About 
60% of patients with limb amputation have phantom pain at 2 years postamputation. 
The pain does not change after 6 months postamputation.3 Neuropathic pain is mul-
tidimensional, including sensory and affective components.4 When superficial tactile 
stimulation is applied to the hand area where acupuncture points are located, activation 
is seen only in somatosensory cortices. However, when the acupuncture points are 
stimulated and pain is experienced by the subjects, activation of additional cortical 
areas, such as anterior cingulate cortex and insula, is observed.5 Sensation (painful 
stimuli) and perception of pain are possibly two different but parallel processes.4
Neuropathic pain is difficult to manage and is associated with poorer physical, 
p  sychological, and social functioning.6–8 Many nonpharmacological modalities 
have been used for management of neuropathic pain with different mechanisms. 
  Transcutaneous electrical nerve stimulation has been used for pain relief.9 The possible 
mechanisms are the gate control theory10 and the release of endogenous opioids.11,12 
The well-accepted mechanism for acupuncture-related pain relief is the release of 
endogenous opioids, which is reversed by naloxone (opioid-antagonist).13,14 Recently, 
it has been found that repetitive painful stimulation (aversiveness) leads to significant 
pain attenuation. The induced pain attenuation is not naloxone-reversible.15 Given 
our recent discovery of systemic effects of voluntary breathing, including   reduction 
in muscle tone,16,17 here we report an innovative intervention that integrates all these 
  modalities by voluntary   breathing, ie, breathing-controlled aversive electrical stimulation 
(BreEStim), to acupuncture points for neuropathic pain management. We hypothesized 
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that BreEStim would have a greater analgesic effect than 
electrical stimulation alone (EStim), because it integrates the 
aforementioned different pain-modifying mechanisms.
Case description
The subject was a 31-year-old white male. He had a 
work-related traumatic injury to his left leg 3.5 years ago 
that resulted in an above-the-knee amputation. At the time 
of study he was working full time. He had no skin issues 
with the residual limb and usually wore his prosthesis about 
12–14 hours a day with a 1-hour break. He could walk several 
blocks without a break.   However, he had severe and constant 
pain and he had to schedule his work break around his pain 
medication s  chedules. Pain was usually constant 6–7/10, 
which decreased to 3–4/10 when medicated. Characteristics 
of phantom pain were mainly burning and electrical shoot-
ing down to the phantom foot. His pain has been stable on 
the pain regime for 4 weeks. He was asked not to change his 
pain regime during the experiment. The patient had no other 
medical issues.
The subject provided informed consent prior to participa-
tion in the study, according to procedures approved by our 
institutional review board. The subject was planned to under-
take the following experimental protocol:   treatment (five 
consecutive days) – washout (1 week) – control (five consecu-
tive days) – washout (1 week) – treatment (5 days) – follow-
up (1 week). Treatment was BreEStim at the self-selected 
aversive (painful) intensity. Each BreEStim session consisted 
of 120 stimuli, which usually took about 30–40 minutes 
including breaks between stimulation trials. In control, the 
subject received only EStim during normal breathing. This 
within-subject crossover design allowed comparisons of effec-
tiveness in reduction of neuropathic pain between BreEStim 
and EStim. The washout/follow-up period allowed washout of 
previous intervention, as well as assessment of possible accu-
mulative or carry-over effect.
The experimental set-up was adopted from our recently 
published protocol.17 The subject was seated comfortably. 
The arms and hands were placed comfortably on the 
experimental table in approximately symmetrical posi-
tions. Surface electrodes were placed over acupuncture 
points Neiguan and Weiguan on the ipsilateral forearm.18 
The intensity of electrical stimulation was started from 0, 
gradually increased to the highest level as tolerated using 
an electrical stimulator (Digitimer DS7A; Welwyn Garden 
City, England). Aversiveness of electrical stimulation is part 
of treatment strategy. However, the intensity of electrical 
stimulation was self-selected.
During EStim, a single-pulse electrical stimulus 
(width 0.1 ms, square wave) was delivered to the forearm 
through surface electrodes randomly every 4–7 seconds. 
During BreEStim, the subject was asked to wear a face mask. 
The face mask was connected indirectly to the experimental 
computer via a pneumotach system (Hans Rodolph, Inc). 
A stimulus was triggered if the airflow reached or exceeded 
40% of maximum airflow during a volitionally effortful 
inhalation.17 Rest was taken upon request. During the entire 
experimental period (4 weeks), the subject maintained the 
same dose and schedule of pain medications. Both BreEStim 
and EStim treatment sessions were performed at the same 
time of the day (between 11 am and noon), such that changes 
in the pain rating could possibly be attributed to stimulation 
effects and not diurnal variation.
Voluntary inhalation played an important role in this 
intervention. Voluntary inhalation was defined as effort-
ful deep and fast inhalation. The subject was instructed to 
take a single isolated deep breath, similar to routine deep 
breaths, but faster and stronger, usually involving obvious 
expansion of the chest wall. It has been reported that there 
are respiratory-specific connections between the insula and 
the activity of pulmonary stretch receptors.19 When wearing 
a face mask, the subject tolerated such breathing very well. 
No hyperventilation was reported.17
The primary outcome measurement included visual 
analog scores (VAS) and modified visual analog scores 
(mVAS). VAS has been extensively used and   validated.20 
mVAS further quantifies the effect of pain reduction 
by measuring duration and amount of change in VAS, 
ie, how much pain was reduced and how long it lasted 
  (reduction × hours). The intensity of electrical stimulation 
was recorded daily during the course of treatment. The aver-
aged intensity for each session was used. The secondary 
outcome measurement was General Well-Being Schedule 
Survey and Center for Epidemiologic Studies Depression 
Scale National Institute of Mental Health Survey to examine 
the possible effect of pain reduction on general well-being, 
depression, and quality of life of the patients. These surveys 
have been well validated and commonly used.21–23 Any side 
effects, tolerance of voluntary breathing via a face mask, and 
psychosocial effects were recorded.
The intensity of electrical stimulation (the lower panels) 
was comparable between BreEStim and EStim interven-
tions (Figure 1). Overall, BreEStim had greater analgesic 
effects than EStim (the upper panels). On average, BreEStim 
produced a 2–4 point reduction on VAS for 3–4 hours after 
each session. EStim produced a 0–2 point reduction on 
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Figure 1 Comparison of analgesic effect between breathing-controlled aversive electrical stimulation (BreEStim) and electrical stimulation only (EStim).
VAS for 1–2 hours. The patient reported that his baseline 
pain level was 5–7/10 prior to each treatment session.
The subject was excited that his intense and constant 
shooting phantom pain disappeared after BreEStim on 
Day 1, despite the fact that the sensation of phantom leg/
foot remained. The shooting phantom pain disappeared after 
the BreEStim protocol (1 week) or at follow-up after EStim 
(a total of 4 weeks). His baseline pain remained the same, 
mainly burning and aching in nature. The subject tolerated 
the first BreEStim and EStim sessions well. Unfortunately, 
the subject did not receive the second BreEStim session, 
because of the experimental error. During reassembling of 
the experimental setting prior to the second BreEStim ses-
sion, one channel was left unwired. The subject received 
sustained electrical stimulation for approximately 5 seconds 
(supposed to be 0.1 ms) at the aversive level during the 
first BreEStim trial on Day 1 of the planned second 5-day 
BreEStim treatment. He felt fearful and anxious about further 
BreEStim trials and reported that his shooting pain came back 
as constant 7/10. The study discontinued at that point. One 
of the authors also tried and experienced the same sustained 
electrical stimulation during normal breathing, and felt tran-
sient pain on the stimulated area for about an hour. During 
a follow-up clinic visit 4 weeks later, the subject reported 
that the baseline burning pain remained the same, while 
the shooting pain gradually subsided to 2/10, lasting about 
1 minute every 3–4 days. He also reported no change in his 
pain regime. The subject showed no carryover effects after 
the intervention. No noticeable overall change in quality of 
life was found based on General Well-Being and Center for 
Epidemiologic Studies Depression Scale surveys, although 
the subject reported that he felt great during and after each 
BreEStim along with pain reduction.
Discussion
This case demonstrates that BreEStim has greater and longer 
analgesic effects than EStim on chronic phantom pain. This 
is possibly attributed to the fact that BreEStim has integrated 
different pain-modifying mechanisms into one intervention, 
including the following:
•	 Electroacupuncture effect. Acupuncture-related analgesic 
effects that are naloxone-reversible are triggered when 
acupuncture points are stimulated.5,24
•	 Habituation to aversive stimuli. Habituation to aversive 
stimuli occurs and is not naloxone-reversible.15 Therefore, 
the two mechanisms could have additive analgesic effects. 
The intensity was about the same between BreEStim and 
EStim groups (Figure 1). It is thus less likely that aversive 
electrical stimulation plays a primary and/or placebo role 
in pain reduction.
•	 Influence of voluntary breathing. Effortful inspira-
tion and expiration requires extensive cortical and 
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  subcortical   activation. The activation is more extensive 
during   voluntary inspiration than voluntary expiration. 
The insular cortex is consistently activated during vari-
ous sensorimotor respiratory tasks.25 The insular cortex 
is critical in affective processing of pain.26
•	 Anterograde amnesia to aversive stimulation. When 
aversive stimulation is delivered during activation of 
the insular cortex, item-specific anterograde amnesia to 
the stimulation occurs.27 In other words, unpleasantness 
of peripheral noxious stimulation is not remembered 
or decreased immediately after voluntary breathing-
controlled electrical stimulation, when the insular cortex 
is activated during voluntary breathing. As such, it is 
expected to facilitate habituation to aversive stimulation 
even at a higher intensity, subsequently increasing the 
analgesic effect of stimulation, thus a positive feedback 
loop. This is likely the case during BreEStim, because the 
subject requested a higher intensity of electrical stimula-
tion gradually during each session, even noxious, for a 
better analgesic effect.
•	 The reward system is triggered. As described, this posi-
tive feedback loop is likely to occur by triggering the 
reward system.28 As observed, the intensity of aversive 
electrical stimulation is driven higher gradually during 
the course of stimulation. However, a large-scale clinical 
study, possibly with imaging studies, such as functional 
magnetic resonance imaging, is needed to corroborate 
the findings and underlying mechanisms.
The accidental finding of disappearance and reappearance 
of shooting phantom pain associated with BreEStim provides 
a unique opportunity to advance our understanding of the 
mechanisms underlying postamputation neuropathic pain. 
This finding implies that shooting stimulus does not change, 
but it is not perceived as aversive after the first BreEStim. 
However, aversive perception of shooting stimulus is likely 
retriggered by an unexpected, fearful sustained electrical 
stimulation in the second BreEStim. It has been reported ear-
lier that when associated with a negative emotional context, 
pain (eg, phantom pain after amputation) could be perceived 
as aversive and retriggered by a stressful life event.3 This 
accidental finding supports the idea that sensory and affec-
tive (unpleasant) components of neuropathic pain (phantom 
pain) are processed in parallel.4 It also suggests that BreEStim 
could modify the affective component, resulting in additional 
analgesic effects. The aforementioned anterograde amnesia27 
may play an important role.
In summary, BreEStim appeared to provide greater anal-
gesic effects than EStim alone in this case. The accidental 
findings associated with BreEStim support the concept 
that neuropathic pain is multidimensional. BreEStim could 
modify the affective component of neuropathic pain.
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